Journal article 756 views 61 downloads
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
Afagh Garjani,
Rod Middleton
,
Rachael Hunter,
Katherine A Tuite-Dalton,
Alasdair Coles,
Ruth Dobson,
Martin Duddy,
Stella Hughes,
Owen R Pearson,
David Rog,
Emma C Tallantyre,
Roshan das Nair,
Richard Nicholas,
Nikos Evangelou
Multiple Sclerosis and Related Disorders, Volume: 52, Start page: 102939
Swansea University Authors:
Rod Middleton , Rachael Hunter
-
PDF | Accepted Manuscript
Distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC-BY-NC-ND) License.
Download (192.05KB)
DOI (Published version): 10.1016/j.msard.2021.102939
Abstract
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
Published in: | Multiple Sclerosis and Related Disorders |
---|---|
ISSN: | 2211-0348 |
Published: |
Elsevier BV
2021
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa56804 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2021-05-07T15:58:40Z |
---|---|
last_indexed |
2021-06-04T03:22:44Z |
id |
cronfa56804 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2021-06-03T08:38:47.8443275</datestamp><bib-version>v2</bib-version><id>56804</id><entry>2021-05-05</entry><title>COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies</title><swanseaauthors><author><sid>005518f819ef1a2a13fdf438529bdfcd</sid><ORCID>0000-0002-2130-4420</ORCID><firstname>Rod</firstname><surname>Middleton</surname><name>Rod Middleton</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>677f0b38990c50c0cc8496382b2e44fc</sid><firstname>Rachael</firstname><surname>Hunter</surname><name>Rachael Hunter</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-05-05</date><deptcode>HDAT</deptcode><abstract/><type>Journal Article</type><journal>Multiple Sclerosis and Related Disorders</journal><volume>52</volume><journalNumber/><paginationStart>102939</paginationStart><paginationEnd/><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>2211-0348</issnPrint><issnElectronic/><keywords>Multiple sclerosis, COVID-19, infection, exacerbation, disease modifying therapies</keywords><publishedDay>1</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-07-01</publishedDate><doi>10.1016/j.msard.2021.102939</doi><url/><notes/><college>COLLEGE NANME</college><department>Health Data Science</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HDAT</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-06-03T08:38:47.8443275</lastEdited><Created>2021-05-05T13:44:54.6129619</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">School of Psychology</level></path><authors><author><firstname>Afagh</firstname><surname>Garjani</surname><order>1</order></author><author><firstname>Rod</firstname><surname>Middleton</surname><orcid>0000-0002-2130-4420</orcid><order>2</order></author><author><firstname>Rachael</firstname><surname>Hunter</surname><order>3</order></author><author><firstname>Katherine A</firstname><surname>Tuite-Dalton</surname><order>4</order></author><author><firstname>Alasdair</firstname><surname>Coles</surname><order>5</order></author><author><firstname>Ruth</firstname><surname>Dobson</surname><order>6</order></author><author><firstname>Martin</firstname><surname>Duddy</surname><order>7</order></author><author><firstname>Stella</firstname><surname>Hughes</surname><order>8</order></author><author><firstname>Owen R</firstname><surname>Pearson</surname><order>9</order></author><author><firstname>David</firstname><surname>Rog</surname><order>10</order></author><author><firstname>Emma C</firstname><surname>Tallantyre</surname><order>11</order></author><author><firstname>Roshan das</firstname><surname>Nair</surname><order>12</order></author><author><firstname>Richard</firstname><surname>Nicholas</surname><order>13</order></author><author><firstname>Nikos</firstname><surname>Evangelou</surname><order>14</order></author></authors><documents><document><filename>56804__19954__920457e166e54e7b904ad8afd61663d0.pdf</filename><originalFilename>56804.AAM.pdf</originalFilename><uploaded>2021-05-20T17:03:23.0322837</uploaded><type>Output</type><contentLength>196659</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2022-05-05T00:00:00.0000000</embargoDate><documentNotes>Distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC-BY-NC-ND) License.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2021-06-03T08:38:47.8443275 v2 56804 2021-05-05 COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies 005518f819ef1a2a13fdf438529bdfcd 0000-0002-2130-4420 Rod Middleton Rod Middleton true false 677f0b38990c50c0cc8496382b2e44fc Rachael Hunter Rachael Hunter true false 2021-05-05 HDAT Journal Article Multiple Sclerosis and Related Disorders 52 102939 Elsevier BV 2211-0348 Multiple sclerosis, COVID-19, infection, exacerbation, disease modifying therapies 1 7 2021 2021-07-01 10.1016/j.msard.2021.102939 COLLEGE NANME Health Data Science COLLEGE CODE HDAT Swansea University 2021-06-03T08:38:47.8443275 2021-05-05T13:44:54.6129619 Faculty of Medicine, Health and Life Sciences School of Psychology Afagh Garjani 1 Rod Middleton 0000-0002-2130-4420 2 Rachael Hunter 3 Katherine A Tuite-Dalton 4 Alasdair Coles 5 Ruth Dobson 6 Martin Duddy 7 Stella Hughes 8 Owen R Pearson 9 David Rog 10 Emma C Tallantyre 11 Roshan das Nair 12 Richard Nicholas 13 Nikos Evangelou 14 56804__19954__920457e166e54e7b904ad8afd61663d0.pdf 56804.AAM.pdf 2021-05-20T17:03:23.0322837 Output 196659 application/pdf Accepted Manuscript true 2022-05-05T00:00:00.0000000 Distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC-BY-NC-ND) License. true eng https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode |
title |
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies |
spellingShingle |
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies Rod Middleton Rachael Hunter |
title_short |
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies |
title_full |
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies |
title_fullStr |
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies |
title_full_unstemmed |
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies |
title_sort |
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies |
author_id_str_mv |
005518f819ef1a2a13fdf438529bdfcd 677f0b38990c50c0cc8496382b2e44fc |
author_id_fullname_str_mv |
005518f819ef1a2a13fdf438529bdfcd_***_Rod Middleton 677f0b38990c50c0cc8496382b2e44fc_***_Rachael Hunter |
author |
Rod Middleton Rachael Hunter |
author2 |
Afagh Garjani Rod Middleton Rachael Hunter Katherine A Tuite-Dalton Alasdair Coles Ruth Dobson Martin Duddy Stella Hughes Owen R Pearson David Rog Emma C Tallantyre Roshan das Nair Richard Nicholas Nikos Evangelou |
format |
Journal article |
container_title |
Multiple Sclerosis and Related Disorders |
container_volume |
52 |
container_start_page |
102939 |
publishDate |
2021 |
institution |
Swansea University |
issn |
2211-0348 |
doi_str_mv |
10.1016/j.msard.2021.102939 |
publisher |
Elsevier BV |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
School of Psychology{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}School of Psychology |
document_store_str |
1 |
active_str |
0 |
published_date |
2021-07-01T04:12:02Z |
_version_ |
1763753824058605568 |
score |
11.021648 |